Exclusive Reports
San Jose Business Journal - New leadership, new location for Parkinson's Institute Conflict of interest questions dog Reed's choice for budget czar Impact of patent ruling likely to extend far into tech sphere Corcept hopeful third test will clear depression treatment Buying
Source: sanjose.bizjournals.com
FDA Panels Urges Changes to Antidepressant Labeling
Forbes - were based on fears that taking anti-depressants could increase the risk of suicide ideation, many psychiatrists worry that the "black-box warning" will backfire -- resulting in more suicides as patients shy away from depression treatment. Expanding
Source: www.forbes.com
Cyberonics to Update FDA on Device Data
MSN MoneyCentral - Additionally, the company could soon face competition from newer depression-treatment devices. Cyberonics will brief a panel of medical experts on two follow-up studies at an FDA meeting on Jan. 26. The agency posted details about the meeting Tuesday
Source: news.moneycentral.msn.com
Building the Bionic Man
Red Herring - Cummins secured U.S. approval for Cyberonics’ depression treatment, which is a pacemaker-like generator that sends mild electrical pulses to stimulate a nerve in the neck that is believed to prod the brain out of depression. But in 2006, Mr. Cummins
Source: www.redherring.com
Click here for more information about childhood depression childhood depression
<< Home